Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Novel treatments for immune thrombocytopenia.

Shih A, Nazi I, Kelton JG, Arnold DM.

Presse Med. 2014 Apr;43(4 Pt 2):e87-95. doi: 10.1016/j.lpm.2014.02.006. Review.

2.
3.

[Treatment Progress of Immune Thrombocytopenia].

Wu B, Wei Y, Zhang Q.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Aug;23(4):1212-5. doi: 10.7534/j.issn.1009-2137.2015.04.060. Review. Chinese.

PMID:
26314476
4.

The pathogenesis of chronic immune thrombocytopenic purpura.

McMillan R.

Semin Hematol. 2007 Oct;44(4 Suppl 5):S3-S11. doi: 10.1053/j.seminhematol.2007.11.002. Review.

PMID:
18096470
5.

Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura.

Kuwana M, Okazaki Y, Ikeda Y.

J Thromb Haemost. 2009 Feb;7(2):322-9. doi: 10.1111/j.1538-7836.2008.03161.x.

6.
7.

Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy.

Andersson PO, Wadenvik H.

Expert Rev Mol Med. 2004 Nov 9;6(24):1-17. Review.

PMID:
15538954
8.

[Autoreactive T cells involved in pathogenesis of ITP as a target for immune therapy].

Kuwana M.

Rinsho Ketsueki. 2000 Jun;41(6):454-7. Review. Japanese. No abstract available.

PMID:
10921340
9.

Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura.

Kuwana M, Nomura S, Fujimura K, Nagasawa T, Muto Y, Kurata Y, Tanaka S, Ikeda Y.

Blood. 2004 Feb 15;103(4):1229-36.

10.

Novel approaches to refractory immune thrombocytopenic purpura.

Bussel JB.

Blood Rev. 2002 Mar;16(1):31-6. Review.

PMID:
11913991
11.

Advances in immunopathogenesis of adult immune thrombocytopenia.

Liu X, Hou Y, Peng J.

Front Med. 2013 Dec;7(4):418-24. doi: 10.1007/s11684-013-0297-8. Review.

PMID:
24264165
12.
13.

The effect of antiplatelet autoantibodies on megakaryocytopoiesis.

McMillan R, Nugent D.

Int J Hematol. 2005 Feb;81(2):94-9. Review.

PMID:
15765775
14.

Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.

McMillan R.

Hematol Oncol Clin North Am. 2009 Dec;23(6):1163-75. doi: 10.1016/j.hoc.2009.08.008. Review.

PMID:
19932426
15.

Epidemiology and pathophysiology of immune thrombocytopenic purpura.

Gernsheimer T.

Eur J Haematol Suppl. 2008 Feb;(69):3-8. doi: 10.1111/j.1600-0609.2007.00998.x. Review.

PMID:
18211567
16.

Current therapies in primary immune thrombocytopenia.

Pels SG.

Semin Thromb Hemost. 2011 Sep;37(6):621-30. doi: 10.1055/s-0031-1291372. Review.

PMID:
22102265
17.

Comparison of platelet immunity in patients with SLE and with ITP.

Lazarus AH, Ellis J, Semple JW, Mody M, Crow AR, Freedman J.

Transfus Sci. 2000 Feb-Apr;22(1-2):19-27.

PMID:
10771375
18.

[Advances in immunological aspects of idiopathic thrombocytopenic purpura].

Kuwana M.

Nihon Rinsho. 2003 Apr;61(4):670-5. Review. Japanese.

PMID:
12718094
19.

Some unsettled questions in childhood thrombocytopenia caused by immunologic platelet destruction (acute and chronic ITP).

Gaedicke G, Schulze H.

Pediatr Blood Cancer. 2006 Oct 15;47(5 Suppl):668-70. Review.

PMID:
16933247
20.

[Idiopathic thrombocytopenic purpura in children].

Gebauer E, Vijatov G.

Med Pregl. 1998 Mar-Apr;51(3-4):127-34. Review. Croatian.

PMID:
9611955
Items per page

Supplemental Content

Support Center